Middle East & Africa Intraosseous Infusion Devices Market

Middle East & Africa Intraosseous Infusion Devices Market Size & Growth (2023 to 2028)

According to the Report, the Size of the Middle East & Africa Intraosseous Infusion Devices Market is valued at USD 368.55 million in 2023 and is expected to grow at a CAGR of 5.3% to reach USD 477.13 million by 2028 during the forecast period 2023 to 2028.

Intraosseous infusion is generally employed in pre-hospital pediatric crises where intravenous delivery of fluids and drugs. Demand for these devices is likely to rise in the coming years due to the increased incidence of various diseases and the number of traumatic surgeries.

Additionally, technologically sophisticated intraosseous devices, such as the EZ-IO, have been introduced to the market, allowing faster and more dependable emergency vascular access than currently available manual procedures. The increased popularity of these devices in hospitals is also due to ongoing training of medical and nursing staff, as well as well-defined guidelines for correct device handling essential for the effective and safe care of patients receiving intraosseous venous access.

Another factor is that the Middle East and Africa is expected to account for a moderate market share in the intraosseous infusion devices market, with the demand steadily increasing due to rising diseases. Soon, the intraosseous infusion devices market will be driven by trauma injury instances and intraosseous infusion devices market expansion.

Extravasation of fluids and drugs into soft tissues after the intraosseous device is one of the most common complications, which can lead to compartment syndrome, a condition caused by elevated pressure within a confined body space.

Iatrogenic fractures, growth plate damage, and infection such as cellulitis and osteomyelitis are all possible adverse effects of using these devices. The Intraosseous Infusion Devices research also includes data on the issues limiting market growth, providing companies with helpful information for strategic planning.

This research report on the Middle East & Africa Intraosseous Infusion Devices Market has been segmented and sub-segmented into the following categories.

By Product Type:

• FAST1 device
• Dieckmann Modified Needle
• BIG device
• EZ-IO device
• Jamshidi Needle
• FASTx device
• NIO

By Technology:

• Battery Powered Driver
• Manual IO Needles
• Impact Driven Devices

By End User:

• Hospitals
• Emergency Medical Ambulatory Surgical Centres
• Services
• Cardiac Care Centres

By Route of Administration:

• Distal Femur
• Sternum
• Distal & Proximal Tibia
• Calcaneus
• Head of Humerus

By Country:

• KSA
• UAE
• Israel
• the rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East & Africa Intraosseous Infusion Devices Market holds a moderate share globally owing to the quick introduction of numerous technologically advanced intraosseous devices by large manufacturers, as well as the rising prevalence of various cardiac illnesses, which are likely to drive the growth of these devices in the Middle East and African market.

The UAE intraosseous infusion devices market is expected to boost the pace of adoption of such devices in developed countries, which is likely to increase the market in this region.

The Saudi Arabia intraosseous infusion devices market dominated this region and rapidly increased. Furthermore, regulatory approvals for intraosseous infusion devices are likely to contribute to the market's growth in the region over the forecast period.

The South African intraosseous infusion devices market is expected to develop due to an increase in new launches of technologically improved goods over the predicted period.

KEY MARKET PLAYERS

Key Market Companies dominating the Middle East & Africa Intraosseous Infusion Devices Market Profiled in the Report are Aero Healthcare, Cook Medical Incorporated, PerSys Medical, Pyng Medical Corp., Teleflex, Biopsybell, Aero Healthcare, etc.,